IMRX (Immuneering) Institutional Ownership: 49.75% (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IMRX Immuneering Corp IMRX
34 GF Score
Price $5.14
! 2 Warning Signs
View Full Analysis

What is Immuneering Institutional Ownership?

Immuneering IMRX -1.82% 34 Institutional Ownership is 49.75% as of Jul. 15, 2026. GuruFocus rates IMRX with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Immuneering's institutional ownership is 49.75%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Immuneering's Insider Ownership is 6.57%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Immuneering's Float Percentage Of Total Shares Outstanding is 75.87%.

Immuneering Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Immuneering's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immuneering Institutional Ownership Chart

Immuneering Historical Data

The historical data trend for Immuneering can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 24.71 25.87 25.61 31.02 31.93 31.88 28.01 27.54 27.73 31.60
IMRX
34GF Score
Immuneering Corp IMRX
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immuneering Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 49.75% mean?
Immuneering (IMRX) has a Institutional Ownership of 49.75% as of Jul. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Immuneering and its competitors.
Is Immuneering's Institutional Ownership too high?
Immuneering's current Institutional Ownership is 49.75%. Overall, Immuneering has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Immuneering's Institutional Ownership compare to MGNX and SLNCF?
Immuneering's Institutional Ownership of 49.75% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Immuneering and its competitors. Immuneering's current Institutional Ownership is 49.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immuneering stock overvalued right now?
Immuneering (IMRX) has a current Institutional Ownership of 49.75%. The current Institutional Ownership is 49.75%. Immuneering's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Immuneering (IMRX), the current Institutional Ownership is 49.75% as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Immuneering Business Description

Address 245 Main Street, Second Floor, Cambridge, MA, USA, 02142
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
34GF Score

Get the complete analysis for IMRX

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.14
Price